Where are mushrooms legal in 2026? The answer depends on the species, the product form and the activity involved. Psilocybin mushrooms remain controlled in most countries, with only a few regulated medical, supervised, ceremonial or decriminalized exceptions. Amanita muscaria is not psilocybin, but that does not automatically make it a lawful food or supplement. Lion’s mane, reishi, chaga and other non-psychoactive mushrooms are generally sold as food or supplements, although extracts, mycelium products, labels and health claims can still require authorization.
This guide was last verified on August 5, 2026. It separates possession, cultivation, sale and supervised medical access because “decriminalized” does not mean “legal to buy,” and an unscheduled mushroom is not necessarily an approved food ingredient. The tables provide general legal information, not advice for a specific purchase, shipment or trip.
What “Legal” Means for Different Mushroom Products
| Legal label | What it usually means | What it does not mean |
|---|---|---|
| Legal or unscheduled | The mushroom or its active compounds are not prohibited under the cited national drug law. | The product is not automatically approved as a food, supplement, medicine or import. |
| Regulated access | Use is permitted inside a licensed medical or supervised framework. | Retail sale, take-home possession and home cultivation may remain illegal. |
| Medical exception | A named clinician, authorized prescriber, clinical trial or exceptional-access process may use psilocybin. | The public cannot buy magic mushrooms recreationally. |
| Decriminalized possession | Small personal-use quantities may be handled administratively or receive reduced enforcement priority. | Production, commercial sale, import and supply remain prohibited unless a separate law permits them. |
| Gray area | The compound is controlled but the whole fungus, spores, sclerotia or another form may not be named clearly. | Silence or inconsistent enforcement is not reliable permission. |
The distinction is especially important in the United States. Psilocybin remains a Schedule I substance under federal DEA rules, even where a state has created protections or licensed services. State law does not authorize interstate transport, mailing or taking psilocybin across an international border.
Psilocybin Laws in the United States, Canada and Mexico
| Jurisdiction | Status on August 5, 2026 | Possession and cultivation | Sale or supervised access |
|---|---|---|---|
| United States – federal law | Psilocybin and psilocin remain Schedule I. Executive Order 14401 accelerates research and review of qualifying psychedelic medicines but does not legalize personal possession. | Illegal without federal research or other specific authorization. | No FDA-approved psilocybin medicine as of the verification date. COMP360 is under rolling FDA review, not approved for public sale. |
| Oregon | Regulated psilocybin services are operational under ORS 475A. | Oregon’s service law does not create a general right to buy, possess or consume psilocybin outside the licensed system. | Adults 21 or older may consume an approved product at a licensed service center after preparation with a licensed facilitator. No prescription or Oregon residency is required, and no product may be taken home. |
| Colorado | State-regulated natural medicine services and a separate personal-use protection apply to adults 21 or older; federal prohibition remains. | State law protects limited personal possession, cultivation, use and uncompensated sharing, subject to location, age and other restrictions. | Licensed healing centers may provide supervised services. Ordinary retail sale and paid transfers outside the regulated system are not permitted. |
| New Mexico | The Medical Psilocybin Act was enacted in 2025, but the public program is not yet operational. | No general personal-use or recreational right was created. | The Department of Health must implement a medical program by December 31, 2027 for qualifying patients in approved settings. Until it opens, the statute should not be described as current patient access. |
| Other U.S. states and cities | Some cities and a small number of states have reduced penalties, deprioritized enforcement or funded research. | Local deprioritization does not erase state or federal offenses. | No lawful retail market follows from a city resolution. Readers should check the exact state statute and municipal policy rather than a national “decriminalized cities” list. |
| Canada | Psilocybin, psilocin and magic mushrooms are controlled. Possession, production and sale are illegal unless Health Canada authorizes them. | Illegal without a licence, exemption or applicable regulatory authorization. Provincial drug-policy pilots do not create a legal mushroom market. | Possible through clinical trials, a case-specific exemption or the Special Access Program for a serious or life-threatening condition when conventional options have failed, are unsuitable or unavailable. |
| Mexico | Psilocybin is controlled, but federal criminal law contains a narrow Indigenous ceremonial exception. | Not generally legal for personal or tourist use. | Article 195 bis can prevent federal prosecution where the quantity and circumstances show use in ceremonies, customs and traditions of recognized Indigenous peoples and communities. This is not a commercial retreat or recreational-sale licence. |
Psilocybin Laws in the Caribbean, Central and South America
Jamaica is the clearest national example in the Americas of an unregulated legal market. Several other countries are regularly advertised as “mushroom-friendly,” but tolerance, a gap in the wording of a schedule and lawful commercial sale are not the same thing.
| Country or territory | Practical legal category | What a careful 2026 description should say |
|---|---|---|
| Jamaica | Unscheduled and unregulated nationally | Jamaican government information confirms that national law did not make psilocybin illegal. Cultivation and an openly operating retreat market exist, but there is no equivalent of pharmaceutical approval or a detailed Oregon-style safety and licensing framework. |
| Bahamas | Frequently described as unscheduled; legal certainty is limited | Secondary legal summaries commonly treat the mushroom itself as lawful while restricting commercial sale. Because an authoritative, current government statement comparable to Jamaica’s is difficult to locate, the Bahamas should not be presented as an unrestricted legal retail market without local legal confirmation. |
| Brazil | Controlled compound; disputed whole-mushroom gray area | ANVISA lists psilocybin and psilocin as prohibited substances and has taken action against unauthorized mushroom extracts marketed with medicinal characteristics. The fact that some sellers rely on the absence of named mushroom species does not make the product clearly legal. |
| Costa Rica | No licensed psilocybin market | National drug rules control psychotropic substances and commercial production, supply and possession for trafficking. Retreats that advertise openly should not be treated as proof of legal authorization. |
| Uruguay | Personal-use possession may avoid criminal punishment; supply remains illegal | Uruguay’s approach to personal drug possession does not create lawful cultivation, import or mushroom sales. |
| Colombia, Ecuador and Peru | No general legal retail or supervised psilocybin program | Personal possession rules and enforcement differ, but psilocybin is controlled and no national consumer market comparable to Jamaica, Oregon or Colorado has been established. |
| Argentina and Chile | Controlled; no general legal access | Possession, production and sale should be treated as prohibited unless a specific research authorization applies. Private-use court decisions or reduced penalties do not legalize supply. |
| Other Caribbean and Latin American jurisdictions | Country-specific law required | Do not infer legality from wild growth, retreat advertising or the absence of arrests. Import, export and sale can be prohibited even where personal possession is rarely prosecuted. |
Psilocybin Laws Across Europe, Including Ukraine and Russia
| Country or group | Status on August 5, 2026 | What is actually permitted |
|---|---|---|
| Netherlands | Psilocybin mushrooms are prohibited; psilocybin-containing sclerotia sold as “magic truffles” remain available under a product-form distinction. | Adults can buy truffles from specialist shops under Dutch rules. This does not legalize fresh or dried magic mushrooms, extraction, international shipping or taking truffles into another country. |
| Czech Republic | A narrow therapeutic psilocybin framework took effect on January 1, 2026. | Therapeutic psilocybin may be administered in specialized healthcare settings under implementing rules. The framework does not legalize recreational mushrooms, home cultivation or take-home products, and actual treatment availability depends on completed clinical and regulatory implementation. |
| Portugal | Small personal-use possession is decriminalized, not legalized. | Possession within the personal-use framework is handled administratively rather than as ordinary criminal possession. Cultivation, production and sale remain illegal. |
| Spain | Psilocybin and psilocin are controlled; private consumption and public possession are treated differently. | Private consumption is not itself a general criminal offense, while public possession can trigger administrative sanctions. Cultivation, distribution and sale can create criminal liability. Spores that contain no psilocybin are not the same legal object as harvested mushrooms. |
| Switzerland | Controlled, with exceptional medical or scientific authorizations possible. | No general public access or legal retail mushroom market. Any therapeutic use depends on professional and federal authorization. |
| United Kingdom | Fresh and prepared magic mushrooms are Class A drugs; psilocybin is a Schedule 1 controlled substance for research and prescribing rules. | No personal-use, cultivation or retail exception. Licensed research remains possible. |
| Ukraine | Psilocybin, psilocin and mushrooms containing them are included in the national controlled-substances framework. | No recreational, retail or home-cultivation pathway. Scientific or medical handling requires the relevant authorization. |
| Russia | Psilocybin, psilocin and fruiting bodies of mushrooms containing either substance are listed in the prohibited national schedule. | Possession, cultivation and sale are not legal consumer activities. |
| Germany, France, Italy and Poland | Controlled; no national legal consumer access program. | Research licences may exist, but possession, cultivation and supply are not legal merely because spores or non-germinated material lack psilocybin. |
| Nordic and Baltic countries | Controlled; no legal retail or personal-cultivation market. | Denmark, Sweden, Norway, Finland, Iceland, Estonia, Latvia and Lithuania should not be described as legal psilocybin destinations. |
| Rest of Europe | Generally prohibited outside research and exceptional medical use. | A reduced penalty for a small quantity is not a right to buy, grow or transport mushrooms. |
Psilocybin Laws in Asia and the Pacific
| Country | Status on August 5, 2026 | Legal access, if any |
|---|---|---|
| Australia | Psilocybin remains controlled, with a narrow medical pathway. | A TGA-authorized psychiatrist may prescribe an unapproved psilocybin product for treatment-resistant depression under strict federal and state or territory controls. Recreational possession, wild harvesting for use, cultivation and ordinary sale remain illegal. |
| New Zealand | Psilocybin is a Class A controlled drug. There is no approved psilocybin medicine. | In 2025 Medsafe authorized one named psychiatrist to prescribe, supply and administer medicinal psilocybin for assessed patients with treatment-resistant depression. That practitioner-specific approval is not general prescribing or public access. |
| Thailand | Magic mushrooms are illegal and treated as a Category 5 narcotic plant; psilocybin is a controlled psychotropic substance. | No recreational or tourist exception. Production, import, export, sale and possession without authorization can carry serious penalties. |
| Vietnam | No legal consumer psilocybin market; psychotropic substances are tightly controlled. | Do not treat tourist availability or online claims as lawful possession, sale or import. Only specifically authorized scientific or medical activity should be assumed lawful. |
| Japan | Psilocybin and psilocin are controlled narcotics; magic mushrooms are not a legal consumer product. | No recreational possession, import or sale. The legal treatment of spores cannot be used as a basis for possessing cultivated psychoactive mushrooms. |
| China | Controlled-substance enforcement is strict; no lawful consumer psilocybin program exists. | Research requires authorization. Possession, production, sale and cross-border transport should be treated as prohibited. |
| India | No regulated national psilocybin access market and significant legal risk under narcotics and psychotropic-substances rules. | Wild occurrence or regional availability does not establish legal possession, cultivation or sale. |
| Nepal | Often described online as “legal by omission,” but no clear licensed framework confirms unrestricted commercial legality. | Treat the status as uncertain rather than legal. Obtain current local advice before possession, sale, retreat activity or transport. |
| Cambodia and Laos | No legal psilocybin market; reported tourist tolerance is not legalization. | Street or restaurant availability does not protect possession, sale or import. |
| Indonesia, Philippines, Singapore and South Korea | Strict drug-control jurisdictions with no public psilocybin access pathway. | Possession, import and sale can carry severe consequences. Do not travel with mushrooms, capsules, extracts or edibles. |
Is Amanita Muscaria Legal?
Amanita muscaria, or fly agaric, contains muscimol and ibotenic acid rather than psilocybin. It is therefore outside many psilocybin schedules, but “not a scheduled psychedelic” and “lawful edible product” are two different tests. The mushroom can cause serious poisoning, and a lawful ornamental specimen can become an unlawful product when it is extracted, packaged for ingestion, imported or sold as food.
| Jurisdiction | Drug-law position | Food and sale position |
|---|---|---|
| United States – federal | Amanita muscaria, muscimol and ibotenic acid are not scheduled under the federal Controlled Substances Act. | The FDA states that Amanita, its extracts and key constituents are unauthorized food additives and do not meet the GRAS safety standard. Food containing them may be adulterated and subject to enforcement. |
| Louisiana | State law specifically restricts materials intended for human consumption that contain Amanita muscaria. | Production, distribution and possession for human consumption are prohibited, with limited exceptions such as ornamental use. |
| Other U.S. states | No broad state-by-state drug ban comparable to Louisiana was confirmed in the reviewed sources. | This does not override federal food law, general poison laws, age rules, local restrictions, product-liability law or state action against intoxicating edibles. |
| Australia and New Zealand | The species is regulated primarily as a toxic fungus rather than a legal psychedelic substitute. | Amanita muscaria is listed among prohibited plants and fungi in the Australia New Zealand Food Standards Code, so it cannot be treated as an ordinary food ingredient. |
| European Union and United Kingdom | National controlled-substance lists differ, and absence from a psilocybin schedule is not EU-wide authorization. | Food-safety, novel-food, medicine, poison and national supplement rules can block extracts, gummies and products marketed for intoxication. Check the destination country’s competent food authority. |
| Canada | Not equivalent to legal psilocybin, but products are still subject to federal food, natural health product and drug classification. | A seller needs the correct product classification and authorization; an online listing is not proof that an ingestible extract is approved. |
| Ukraine and Russia | Do not transfer the psilocybin analysis to Amanita. The species and muscimol require a separate review of the current national substance list. | Even if possession of the raw fungus is not expressly scheduled, sale as food, supplement or medicine can still be restricted. The broad claim that Amanita is simply “legal” or “illegal” nationwide is not sufficiently precise. |
| Thailand, Vietnam and other Asian countries | No region-wide rule exists. | Import, toxic-food and medicinal-product laws may apply even where muscimol is not named in a narcotics schedule. A country-specific written determination is safer than relying on marketplace availability. |
Amanita should not be marketed as “legal magic mushrooms.” That phrase hides both the different pharmacology and the food-safety rules that regulators may use even when drug scheduling does not apply.
Are Lion’s Mane, Reishi, Chaga and Cordyceps Legal?
Non-psychoactive functional mushrooms are not controlled drugs merely because they are mushrooms. Lion’s mane (Hericium erinaceus), reishi (Ganoderma lucidum), chaga (Inonotus obliquus), turkey tail (Trametes versicolor) and permitted Cordyceps products can generally be bought and possessed. The compliance question is usually the exact species, fruiting body versus mycelium, extraction process, intended use and claims on the label.
| Market | General position | Important restriction |
|---|---|---|
| United States | Functional mushrooms can be sold as conventional foods or dietary supplements when the ingredient and product comply with the relevant federal rules. | A new dietary ingredient may require notification. Claims that a product diagnoses, treats, cures or prevents disease can make it an unapproved drug. Legal possession does not mean every imported extract or health claim is compliant. |
| Canada | Foods and licensed Natural Health Products containing functional mushrooms are available. | A Natural Product Number on the label helps confirm that a specific NHP was licensed. Product form and medicinal claims determine the regulatory pathway. |
| European Union | Common culinary forms and several fruiting-body extracts can be lawful, subject to food and supplement rules. | Form matters. In 2025 EU consultation decisions treated fruiting-body extract powders of lion’s mane, reishi and maitake as not novel, and chaga fruiting-body extract as not novel in food supplements. Dehydrated mycelium powders of lion’s mane and reishi were classified as novel foods and need authorization before lawful marketing. Cordyceps status depends on the species, material and production method. |
| United Kingdom | Functional mushrooms are not controlled drugs. | Retained novel-food rules, supplement labeling, food-safety requirements and medicines-by-presentation rules still apply. |
| Ukraine and Russia | Functional species are not treated as psilocybin mushrooms solely because of their taxonomy. | Food, specialized-food, supplement, labeling, sanitary and import rules apply. Sellers should verify the exact species and product registration rather than claim that every extract is unrestricted. |
| Thailand, Vietnam and other Asian markets | Many culinary and traditional mushroom products are lawfully sold. | Extracts, capsules, novel ingredients and medical claims may require food, traditional medicine, supplement or drug registration. Approval in the United States or EU does not carry over automatically. |
The European Commission’s novel-food consultation register illustrates why a species-only answer is incomplete: fruiting-body extract and dehydrated mycelium from the same mushroom can receive different regulatory treatment.
How to Check a Mushroom Product Before Buying or Traveling
- Identify the Latin species and active compounds. “Mushroom blend” is not enough. Psilocybin, muscimol and a non-psychoactive fruiting-body extract belong to different legal categories.
- Check the product form. Fresh mushroom, dried mushroom, sclerotium, spore, mycelium powder, standardized extract, gummy and prescription preparation may be regulated differently.
- Check the action, not only possession. Cultivation, processing, gifting, sale, advertising, import and export can each have a different rule.
- Use the destination’s current government source. A store page, retreat advertisement or marketplace listing does not establish legality.
- Recheck borders separately. A product lawfully purchased in one jurisdiction can become illegal as soon as it is mailed or carried into another.
- For supplements, verify authorization and claims. Look for the required local licence, product number, novel-food authorization or compliant label. Avoid products promoted as cures or substitutes for medical treatment.
Laws and implementation can change faster than older “mushroom legality maps.” For psilocybin, verify both national and state or provincial law. For Amanita and functional mushrooms, verify food, supplement and import rules in addition to the controlled-substances list.
